ARQL
Arqule, Inc.
A biopharmaceutical company in Massachusetts that made targeted small-molecule cancer drugs, especially kinase inhibitors. Founded in 1993, it ran automated array-based chemistry to help big drug companies test compounds before shifting to develop its own therapies. Its name blends "array" and "quantitative" chemistry, and Merck bought the firm in 2020.
CUSIP: 04269E107HealthcareUS1 holder